Ennan Guan
Division of Therapeutic Proteins
CBER, Food and Drug Administration
Bethesda
USA
Name/email consistency: high
- Amino-terminal processing of MIP-1beta/CCL4 by CD26/dipeptidyl-peptidase IV. Guan, E., Wang, J., Norcross, M.A. J. Cell. Biochem. (2004)
- Natural truncation of the chemokine MIP-1 beta /CCL4 affects receptor specificity but not anti-HIV-1 activity. Guan, E., Wang, J., Roderiquez, G., Norcross, M.A. J. Biol. Chem. (2002)